rs368123079

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001257096.2(PAX1):​c.1282+12A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.005 in 1,509,864 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0031 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 21 hom. )

Consequence

PAX1
NM_001257096.2 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -3.28

Publications

0 publications found
Variant links:
Genes affected
PAX1 (HGNC:8615): (paired box 1) This gene is a member of the paired box (PAX) family of transcription factors. Members of the PAX family typically contain a paired box domain and a paired-type homeodomain. These genes play critical roles during fetal development. This gene plays a role in pattern formation during embryogenesis and may be essential for development of the vertebral column. This gene is silenced by methylation in ovarian and cervical cancers and may be a tumor suppressor gene. Mutations in this gene are also associated with vertebral malformations. [provided by RefSeq, Mar 2012]
PAX1 Gene-Disease associations (from GenCC):
  • otofaciocervical syndrome 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 20-21709456-A-C is Benign according to our data. Variant chr20-21709456-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445455.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00313 (477/152272) while in subpopulation NFE AF = 0.00559 (380/68006). AF 95% confidence interval is 0.00512. There are 1 homozygotes in GnomAd4. There are 231 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 21 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAX1NM_001257096.2 linkc.1282+12A>C intron_variant Intron 4 of 4 ENST00000613128.5 NP_001244025.1
PAX1NM_006192.5 linkc.1282+12A>C intron_variant Intron 4 of 4 NP_006183.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAX1ENST00000613128.5 linkc.1282+12A>C intron_variant Intron 4 of 4 1 NM_001257096.2 ENSP00000481334.1
PAX1ENST00000398485.6 linkc.1282+12A>C intron_variant Intron 4 of 4 5 ENSP00000381499.2
PAX1ENST00000444366.2 linkc.1210+12A>C intron_variant Intron 3 of 3 2 ENSP00000410355.2
PAX1ENST00000485038.1 linkn.*179A>C downstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00313
AC:
477
AN:
152154
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00559
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00261
AC:
308
AN:
118064
AF XY:
0.00253
show subpopulations
Gnomad AFR exome
AF:
0.000560
Gnomad AMR exome
AF:
0.00130
Gnomad ASJ exome
AF:
0.000167
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000862
Gnomad NFE exome
AF:
0.00574
Gnomad OTH exome
AF:
0.00222
GnomAD4 exome
AF:
0.00521
AC:
7068
AN:
1357592
Hom.:
21
Cov.:
30
AF XY:
0.00511
AC XY:
3417
AN XY:
668084
show subpopulations
African (AFR)
AF:
0.000848
AC:
26
AN:
30674
American (AMR)
AF:
0.00111
AC:
36
AN:
32362
Ashkenazi Jewish (ASJ)
AF:
0.0000860
AC:
2
AN:
23246
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35470
South Asian (SAS)
AF:
0.000186
AC:
14
AN:
75442
European-Finnish (FIN)
AF:
0.00159
AC:
56
AN:
35268
Middle Eastern (MID)
AF:
0.000502
AC:
2
AN:
3986
European-Non Finnish (NFE)
AF:
0.00631
AC:
6720
AN:
1064642
Other (OTH)
AF:
0.00375
AC:
212
AN:
56502
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
350
700
1051
1401
1751
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00313
AC:
477
AN:
152272
Hom.:
1
Cov.:
32
AF XY:
0.00310
AC XY:
231
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00120
AC:
50
AN:
41570
American (AMR)
AF:
0.00203
AC:
31
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.000942
AC:
10
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00559
AC:
380
AN:
68006
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00219
Hom.:
0
Bravo
AF:
0.00288
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PAX1: BS2 -

Jun 01, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 30, 2022
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1282+12A>C variant in PAX1 is classified as likely benign because it is not located within the splice consensus sequence and computational splice prediction tools do not predict an impact on splicing. It has also been identified in 0.558% (339/60720) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org) and in one individual with Klippel-Feil syndrome (McGaughran 2003 PMID: 12774041). ACMG/AMP Criteria applied: BP4, BP7. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.025
DANN
Benign
0.59
PhyloP100
-3.3
Mutation Taster
=21/79
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368123079; hg19: chr20-21690094; API